| Authors: |
McCourt CK; Washington University School of Medicine, St. Louis, Missouri., Wei Z; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Kalinsky K; Winship Cancer Institute at Emory University, Atlanta, Georgia., Gray R; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., Wang V; Dana Farber Cancer Institute - ECOG-ACRIN Biostatistics Center, Boston, Massachusetts., McShane LM; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Rubinstein LV; Biometric Research Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, Bethesda, Maryland., Williams PM; Frederick National Laboratory for Cancer Research, Frederick, Maryland., Hamilton SR; City of Hope National Medical Center, Duarte, California., Force J; Duke University Medical Center, Durham, North Carolina., Pakanati A; Kaiser Permanente - Panorama City, Panorama City, California., Tricoli JV; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Conley BA; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Arteaga C; UT Southwestern Simmons Comprehensive Cancer Center, Dallas, Texas., Harris LN; Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., O'Dwyer PJ; University of Pennsylvania, Philadelphia, Pennsylvania., Chen AP; Developmental Therapeutics Clinic, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland., Flaherty KT; Massachusetts General Hospital Cancer Center, Boston, Massachusetts. |
